1. "Hematologic Malignancies, Division of"
  2. "The Oncologist"
Formats
  1. Journal Article (22)
  2. Review (4)
  3. Meeting Abstract (3)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (31)
  2. Hematologic Malignancies, Division of (31)
  3. Center for Hematologic Malignancies (18)
  4. GSK Faculty (13)
  5. Solid Tumor Oncology Division (13)
  6. Survivorship Research (11)

More Groups

People
  1. Alexander Shoushtari (5)
  2. Michael Postow (5)
  3. Jedd Wolchok (4)
  4. Margaret Callahan (4)
  5. Matthew Matasar (4)
  6. Sandra D'Angelo (4)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (3)
  5. 2019 (6)
  6. 2018 (1)

More Years

Publications
  1. The Oncologist (31)
Publishers
  1. Oxford University Press (31)

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Functional and translational consequences of immunometabolic coevolution in ccRCC
    Meeting Abstract

    Reznik, E.; Tang, C.; Xie, A.; Liu, E. M.; Kuo, F.; Kim, M.; Golkaram, M.; Chen, Y.; Gupta, S.; Motzer, R.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin by CD30 expression in non-Hodgkin lymphoma
    Journal Article

    Jagadeesh, D.; Horwitz, S.; Bartlett, N. L.; Kim, Y.; Jacobsen, E.; Duvic, M.; Little, M.; Trepicchio, W.; Fenton, K.; Onsum, M.; more...
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Translating the biology of diffuse large B-cell lymphoma into treatment
    Review

    Danilov, A. V.; Magagnoli, M.; Matasar, M. J.
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Selinexor, a first in class, nuclear export inhibitor for the treatment of advanced malignant peripheral nerve sheath tumor
    Journal Article

    Al-Ezzi, E.; Gounder, M.; Watson, G.; Mazzocca, A.; D'Angelo, S. P.; Bravetti, J.; Wang, H.; Abdul Razak, A.; Vincenzi, B.
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Approach to cancer-associated thrombosis: Challenging situations and knowledge gaps
    Review

    Wang, T. F.; Billett, H. H.; Connors, J. M.; Soff, G. A.
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Training oncologists in the time of COVID-19
    Editorial

    Choudhury, N.; Shoushtari, A.
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Eosinophilic fasciitis following checkpoint inhibitor therapy: Four cases and a review of literature
    Review

    Chan, K. K.; Magro, C.; Shoushtari, A.; Rudin, C.; Rotemberg, V.; Rossi, A.; Lezcano, C.; Carrino, J.; Fernandez, D.; Postow, M. A.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save